Stay updated on Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Prasinezumab in Early Parkinson's Disease Clinical Trial page.

Latest updates to the Prasinezumab in Early Parkinson's Disease Clinical Trial page
- Check7 days agoChange DetectedThe history now shows Revision: v3.6.5, indicating a newer page revision. This is a maintenance/metadata update rather than a substantive change to the study data or its description.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous v3.6.3, indicating a software update to the ClinicalTrials.gov site.SummaryDifference0.0%

- Check29 days agoChange DetectedCore trial data sections were added to the study record history on 2026-07-13, including Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, Arms and Interventions, and Study Status. A deletion was recorded on 2026-03-17.SummaryDifference0.5%

- Check43 days agoChange DetectedThe page history now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a minor release/update to the page's build metadata.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision entry v3.6.2 was added to the record history. The previous v3.6.0 entry was removed.SummaryDifference0.1%

- Check64 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating enrollment has ended. The history also adds a new revision tag v3.6.0 and removes the previous revision v3.5.5.SummaryDifference0.2%

Stay in the know with updates to Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prasinezumab in Early Parkinson's Disease Clinical Trial page.